Abstract. All known glycophosphatidylinositol (GPI)-anchored membrane proteins contain a COOH-terminal hydrophobic domain necessary for signalling anchor attachment. To examine the requirement that this signal be at the COOH terminus of the protein, we constructed a chimeric protein, DAFhGH, in which human growth hormone (hGH) was fused to the COOH terminus of decay accelerating factor (DAF) (a GPIanchored protein), thereby placing the GPI signal in the middle of the chimeric protein. We show that the fusion protein appears to be processed at the normal DAF processing site in COS cells, producing GPIanchored DAF on the cell surface. This result indicates that the GPI signal does not have to be at the COOH terminus to direct anchor addition, suggesting that the absence of a hydrophilic COOH-terminal extension (beyond the hydrophobic domain) is not a necessary requirement for GPI anchoring. A similar DAFhGH fusion, containing an internal GPI signal in which the DAF hydrophobic domain was replaced with the signal peptide of hGH, also produced GPI-anchored cell surface DAF. The signal for GPI attachment thus exhibits neither position specificity nor sequence specificity. In addition, mutant DAF or DAFhGH constructs lacking an NH2-terminal signal peptide failed to produce GPI-anchored protein, suggesting that membrane translocation is necessary for anchor addition.
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iverse class of integral membrane proteins is now known to be anchored to the plasma membrane by a glycophosphatidylinositol (GPI) ~ structure covalently attached to the COOH terminus of the protein (for reviews see Cross, 1990; Low, 1989; Ferguson and Willianas, 1988; Low and Saltiel, 1988) . The GPI anchor contains phosphatidylinositol, carbohydrate, and ethanolamine, and is thought to be preassembled in the ER (Masterson et al., 1989) . Attachment to the protein is directed by a signal at the COOH terminus of the protein (Caras et al., 1987a) and involves a processing event in which 17-31 COOHterminal residues are removed from the nascent chain immediately before or concomitant with anchor addition (Boothroyd et al., 1981; Tse et al., 1985) , the GPI anchor being added to the new COOH terminus. Anchor addition apparently takes place in the ER (Bangs et al., 1985 (Bangs et al., , 1986 Ferguson et al., 1986) , after which the protein is transported to the cell surface via the Golgi apparatus.
Although all GPI-anchored proteins presumably contain a signal for anchor attachment that is recognized by a common pathway, there is little or no primary sequence homology. The only commonly observed feature is the presence of a short hydrophobic domain (15-20 residues) at the COOH terminus of the protein (Low, 1989; Ferguson and Williams, 1988) . This hydrophobic domain is absolutely necessary (although insufficient) for anchor attachment, deletion or shortening of the hydrophobic stretch leading to abolition of anchor attachment and secretion of the protein Berger et al., 1988) . Using the GPI-anchored protein decay accelerating factor (DAF) t (Davitz et al., 1986; Medof et al., 1986) as a model system to analyze the signal for anchor attachment, we have previously shown that replacement of the COOH-terminal hydrophobic domain either with a signal peptide that normally functions in protein translocation, or with a random hydrophobic sequence, results in efficient and correct processing, producing GPIanchored DAF on the cell surface (Caras and Weddell, 1989) . These observations suggest that the function of the COOH-terminal hydrophobic domain in anchor attachment depends on its hydrophobicity rather than its precise sequence. In addition to the hydrophobic domain, anchor attachment requires a second element believed to be the cleavage/attachment site for the anchor , generally located 10-12 residues NH2-terminal to the hydrophobic domain. Recent experiments have shown that Ser-319 (occurring 12 residues NH2-terminal to the hydrophobic domain) is the GPI-linked residue of DAF, indicating that 28 residues are removed from the nascent chain during processing (Moran et al., 1991) .
It has been suggested that a third feature is important for GPI attachment: the absence of a hydrophilic tail COOHterminal to the hydrophobic domain (Berger et al., 1989; Cross, 1990) . This report focuses on the question of position specificity of the GPI signal and asks, by adding a long hydrophilic extension to the COOH terminus of DAF, whether an internally positioned (as opposed to COOHterminal) GPI signal can function in anchor attachment. We also examine whether translocation into the ER is necessary for anchor addition and ask if the COOH-terminal hydrophobic domain can function as a translocation signal in the absence of an NH2-terminal signal peptide. 
Materials and Methods

Materials
Recombinant Plasmids
A DAFhGH fusion was constructed by cloning a full-length DAF cDNA (Caras et al., 1987 b) and a full-length hGH cDNA (DeNoto et al., 1981) in tandem into the M13 vector nap 18. Deletion mutagenesis (Zoller and Smith, 1982) was then used to delete unwanted 3' sequence (i.e., the 3' untranslated region) from the DAF cDNA and unwanted 5' sequence from the hGH cDNA, thereby creating an in-frame fusion in which the last residue of DAF was fused to the first residue of mature hGH. To construct DAFSig2hGH, a cDNA encoding A1 DAE which lacks the COOH-terminal hydrophobic domain of DAF , was used in place of wildtype DAF and the last residue of A1 DAF was fused to the first residue of the signal peptide of pre-hGH. DAF-SiglhGH was constructed by fusing the previously described protein DAF-Sigl (Caras and Weddell, 1989) , containing residues -26 to -6 of the hGH signal peptide in place of the DAF COOH-terminal hydrophobic domain, to mature hGH as described above. The recombinant DNAs were verified by sequencing before being inserted into a mammalian expression vector between a cytomegalovirus enhancer-promoter and an SV40 polyadenylation sequence (Eaton et al., 1986) . Sig-mutants, lacking the NH2-terminal signal peptide of DAF, were constructed by deletion mutagenesis in M13, verified by sequencing, and cloned into a mammalian expression vector as above.
Transfections, Metabolic Labeling, and Immunoprecipitation
COS cells were transfected using the DEAE dextran method as described by Selden (1987) using 2 tzg of plasmid DNA per 35-ram dish and DEAEDextran at 400/~g/ml. Metabolic labeling of cells with [35S]methionine and analysis of proteins by immunoprecipitation was as previously described Caras and Weddell, 1989) .
Immunofluorescent Labeling of Cells
Immunofluorescent labeling of intact cells (cell surface labeling) or permeabilized cells (internal labeling) was carried out essentially as described (Cat'as et al., 1987b) except that 0.5% Triton X-100/PBS was used to permeabilize the cells. Cells were incubated with a mAb against DAF or a purified rabbit antibody against hGH, followed by fluorescein-conjugated goat anti-mouse or -rabbit antiserum (Cappel Laboratories).
Results
All GPI-anchored membrane proteins contain a COOHterminal hydrophobic domain required for anchor addition Caras and Weddell, 1989; Berger et al., 1988) . To investigate whether this hydrophobic domain must be at, or very near, the COOH terminus, we constructed a fusion protein, DAFhGH, containing mature hGH fused inframe to the COOH terminus of DAF (Fig. 1 ). This fusion effectively repositions the COOH-terminal hydrophobic domain of DAF, placing it in the middle of the fusion protein between two large hydrophilic domains. The position of the cleavage/attachment site for the anchor (Ser-319) (Moran et al., 1991) , relative to the hydrophobic domain, remains unchanged. In addition, we constructed two deletion mutants, Sig-DAF and Sig-DAFhGH ( Fig. 1 ) in which the NH2-terminal signal peptide of DAF was removed from both wildtype DAF and the DAFhGH fusion protein. These deletion mutants address the questions: (a) Can the COOH-terminal hydrophobic domain serve as a membrane translocation signal in addition to, or simultaneous with, triggering GPI anchor attachment; and (b) is translocation across the membrane of the ER necessary for GPI attachment?
Immunoprecipitation Analysis
The cDNAs encoding these proteins were transiently expressed in COS cells under control of the cytomegalovirus promoter. The cells were labeled with [35S]cysteine and the expressed proteins were immunoprecipitated from both the cell extracts and culture media using antibodies against either DAF or hGH. As previously reported , wild-type DAF is localized primarily in the cell lysate as a heterogenous, extensively glycosylated ~o70-kD mature form, and two ,x,40-kD, partially glycosylated, precursor forms (Fig. 2 , lane 2). In addition, the culture medium contains an ,~65-kD shed form (Fig. 2, lane 1/) . The cell lysate from cells transfected with the DAFhGH expression vector contained the ~40-and ,'o70-kD DAF species, both of which immunoprecipitated with the anti-DAF antibody but not with the anti-hGH antibody (Fig. 2, lanes 4 and 6) , suggesting cleavage of the fusion protein and release of the NH2-terminal DAF portion. The lysate also contained an *63-kD species that immunoprecipitated with both antibodies (anti-DAF and anti-hGH) and presumably represents uncleaved, partially or unglycosylated fusion protein (predicted molecular weight = 66 kD). A larger, '~80-kD species, probably a glycosylated form of the uncleaved fusion protein, was secreted into the culture medium and coprecipitated with antibodies against both DAF and hGH (Fig. 2, lanes 13 and 15) .
In addition, low levels of an ,~27-kD hGH fragment, presumably the cleaved COOH-terminal portion of the fusion protein, was detected in the cell lysate using anti-hGH antiserum (lane 6). (The estimated molecular weight of this fragment, which should contain mature hGH plus 28 COOH-terminal residues of DAE is ~26-kD). These data suggest that the DAFhGH fusion protein was in part cleaved to yield an NH2-terminal DAF fragment and a COOHterminal hGH fragment, both of which remained cell associated, and in part secreted as an intact fusion protein.
Cells expressing Sig-DAFhGH, which lacks an NH2-terminal signal peptide, contained low levels ofa 60-kD protein in the cell lysate. Although the molecular weight suggests that this species represents uncleaved fusion protein, it was detectable only with the anti-hGH antibody (lane 7). The slightly lower molecular weight of this 60-kD species relative to the 63-kD species generated by the DAFhGH fu- 18) shows a secreted protein of lower molecular weight than the COOH-terminal hGH fragment produced by cleavage of the DAFhGH fusion (lane 6), suggesting that the DAFhGH fusion protein was cleaved within the DAF sequence (possibly at the normal anchor addition site) rather than at the fusion junction. (Mature hGH has a molecular weight of ,x,23 kD and electrophoreses with the dye front in this gel system).
lmmunofluorescence Microscopy
To determine the cellular localization of protein(s) encoded by the DAFhGH expression plasmid, the cells were exam- -9) and the corresponding culture media (lanes 10-18) using either anti-DAF or anti-hGH antibodies as indicated. Lysate and media fractions thus represent equal numbers of cells and the exposure times were equivalent. The DNAs used for transfection are indicated above each lane; DNA was omitted from mock transfected control cultures. Additional controis included transfection with RSV.CAT (to control for leakage of cytoplasmic proteins into the medium) followed by immunoprecipitation with an anti-CAT antibody (lanes 8 and 17), and transfection with an hGH expression plasmid, followed by immunoprecipitation with anti-hGH (lanes 9
and 18).
ined by immunofluorescence microscopy using antibodies directed against either DAF or hGH. Cell-surface labeling of intact cells indicated that DAF derived from the DAFhGH fusion is on the cell surface (Fig. 3 b) as is wild-type DAF (Fig. 3 a) . HGH was not detected on the cell surface (data not shown). Staining of permeabilized cells with the antihGH antibody showed intense labeling of the ER and Golgi apparatus but not the plasma membrane (Fig. 3 e) , whereas the anti-DAF antibody stained both the cell boundaries (plasma membrane) and internal organeUes (Fig. 3, c and d ). These data suggest that the cleaved DAF fragment produced from the DAFhGH fusion is targeted to the cell surface while the uncleaved fusion protein is confined to the organelles of the secretory pathway. No significant staining of either DAF or hGH could be detected in cells transfected with Sig-DAF or Sig-DAFhGH (data not shown), suggesting either low expression levels (possibly because of instability of nontranslocated proteins) or poor recognition by the antibodies due to incorrect folding in the cytoplasm.
PIPLC Release Indicating the Presence of a GPI Anchor
To determine whether the cell surface DAF produced from the DAFhGH fusion is anchored by a GPI anchor, transfected COS cells were incubated with purified PIPLC, and the levels of DAF in the incubation supernatants were measured by an ELISA assay. PIPLC treatment of cells transfected with the DAFhGH expression vector resulted in a PIPLC-dependent release of DAF from the cell surface (Ta- [
3H]Ethanolamine Labeling
To verify that the cell surface DAF produced from the DAFhGH fusion is anchored by a GPI membrane anchor, transfected COS cell were metabolically labeled with [3H]ethanolamine and analyzed by immunoprecipitation using an anti-DAF antibody. Cell lysates from cells transfected with DAFhGH contained a labeled •70-kD doublet (Fig. 4 , lane 4) that comigrated with authentic DAF (Fig. 4 , lane 2), confirming that correctly processed GPI-anchored DAF is produced from the DAFhGH fusion. In addition, the media from cells expressing either DAF or DAFhGH con- , and e). To detect cell surface expression (a and b), cells were fixed but not permeabilized, and labeled as described in Materials and Methods using an anti-DAF antibody. To detect intracellular protein (c, d, and e), cells were fixed and permeabilized as described in Materials and Methods labeled with either an anti-DAF or anti-hGH antibody as indicated.
tained an ~68-kD ethanolamine-labeled species, believed to represent a released form of DAF resulting from a cleavage within the GPI anchor . The ~80-kD uncleaved hGHDAF fusion protein secreted to the medium * A1 DAF is a deletion mutant of DAF that lacks a COOH-terminal hydrophobic domain, fails to become GPI-anchored, and is secreted ).
( Fig. 2) was not labeled with [3H]ethanolamine, nor were any ethanolamine-labeled bands detected in cells expressing Sig-DAF or Sig-DAFhGH.
An Internally Positioned Signal Peptide Can Direct GPI Attachment
We have previously shown that a signal for protein secretion can direct GPI anchor attachment when positioned at the COOH terminus of DAF, in place of the DAF hydrophobic domain (Caras and Weddell, 1989) . To determine whether a signal peptide located internally within a protein can similarly direct GPI attachment, we constructed the fusion protein DAF-Sig2hGH (Fig. 1) in which a DAF sequence lacking the COOH-terminal hydrophobic domain was fused to pre-hGH. The NH2-terminal signal peptide of hGH thus replaces the COOH-terminal hydrophobic domain of DAF and is followed by the complete mature hGH coding sequence. The position of the cleavage/attachment site relative to the hydrophobic signalling domain, remains unchanged. 5) and media (lanes 6-10) were analyzed by immunoprecipitation using an anti-DAF antibody. DNA was omitted from mock-transfected controls.
To eliminate potential complications caused by cleavage of the internal signal peptide by signal peptidase, a similar fusion, DAF-SiglhGH (Fig. 1) , was constructed in which the signal peptidase cleavage site (residues -5 to -1) was deleted from the hGH signal peptide, thus preventing possible cleavage of the fusion protein near the fusion junction. This fusion protein is analogous to the previously described protein DAF-Sigl, containing a truncated hGH signal peptide in place of the DAF COOH-terminal hydrophobic domain (Caras and Weddell, 1989) , but the entire hGH coding region has now been added as a COOH-terminal extension. COS ceils were transfected with expression plasmids encoding DAF-Sig2hGH or DAF-SiglhGH, and then labeled with [35S]cysteine. The proteins were analyzed by immunoprecipitation, revealing a pattern similar to that observed with the DAFhGH fusion (data not shown), suggesting that, like DAFhGH, these fusion proteins were in part cleaved to yield both DAF and hGH fragments, and in part secreted as intact fusion proteins. There was no significant difference in the polypeptides produced from the DAF-SiglhGH and DAFSig2hGH fusions, and the absence of a fragment corresponding to mature hGH in either the cell lysate or culture medium suggests that the internally positioned hGH signal peptide was not cleaved by signal peptidase. Immunofluorescent staining of nonpermeabilized COS cells transfected with DAF-Sig2hGH or DAF-SiglhGH revealed that DAF (but not hGH) was expressed on the cell surface (Fig. 5, top) , data shown only for DAF-Sig2hGH). Staining of permeabilized cells indicated that hGH was present in the secretory pathway (the ER and Golgi apparatus were intensely stained; Fig. 5, bottom) , but not on the plasma membrane whereas DAF could be detected on the plasma membrane as well as in these internal organelles (Fig. 5,  middle) .
To determine whether cleavage of DAF-SiglhGH or DAFSig2hGH produces GPI-anchored DAF, transfected COS cells were labeled with pH]ethanolamine and then analyzed by immunoprecipitation. The DAF-SiglhGH and DAF- Sig2hGH products (Fig. 6 , lanes 2 and 3) were compared with authentic DAF (lane 4) and DAF-Sig2 (lane 5), containing a COOH-terminal hGH signal peptide in place of the DAF hydrophobic domain (Caras and Weddell, 1989) . All the cell lysates contained similar [3H]ethanolamine-labeled bands corresponding to the 40-kD precursor and ,,o70-kD mature form of authentic DAF, indicating that the DAFSiglhGH and DAF-Sig2hGH fusions were processed at or near the normal DAF processing site, giving rise to GPIanchored cell surface DAE These results indicate that an internally positioned signal peptide can function in GPI attachment, suggesting that the requirement for a COOH-terminal hydrophobic domain is neither sequence specific nor position specific.
D i s c u s s i o n The Signal for GPI Attachment Does Not Have To Be at the COOH Terminus
Previous reports have shown that GPI attachment is directed by a COOH-terminal signal consisting of two elements: a hydrophobic domain and a cleavage attachment site, located ,~10-12 residues NH:-terminal to the hydrophobic domain . In addition, it has been suggested that the absence of a hydrophilic (cytoplasmic) tail may be an important feature of the GPI signal (Berger et al., 1980; Cross 1990) . In this report, we examined the requirement that the GPI signal be at the COOH terminus of the protein. Our results show that repositioning of the GPI signal of DAF to the middle of a large hydrophilic fusion protein allows correct processing, apparently at or near the normal processing site, producing authentic GPI-anchored DAF on the cell surface. The question as to whether the absence of a hydrophilic COOH-terminal tail is an important feature of the GPI signal, has been controversial. The presence or absence of the 21-amino acid cytoplasmic tail present in the transmembrane but not the GPI-anchored form of the human IgG Fc receptor (FcqcRIII) is apparently not the critical feature that determines GPI anchoring, and molecules containing this short, COOH-terminal extension can become GPI anchored (Lanier et al., 1980; Kurosaki and Ravetch, 1989) . On the other hand, replacement of the COOH-terminal hydrophobic domain of placental alkaline phosphatase with the transmembrane-cytoplasmic domains of vesicular stomatitis virus glycoprotein completely abolished GPI attachment, leading to the suggestion that the absence of a cytoplasmic tail may be important for GPI anchoring (Berger et al., 1989) . Our data now indicate that despite the presence of a long hydrophilic extension of 191 amino acids, DAF molecules can be targeted to the plasma membrane via a GPI anchor, sug- gesting that the absence of a hydrophilic tail is not a critical feature of the GPI signal. A fraction of these altered DAF molecules escape processing however and are secreted as intact fusion protein, suggesting that an internal GPI signal may be recognized less efficiently than a COOH-terminal signal.
All known GPI-anchored proteins examined to date contain hydrophilic extensions (beyond the COOH-terminal hydrophobic domain) of no more than a few amino acids. Our results suggest that this may represent an evolutionary adaptation rather than a strict functional constraint. Since the COOH-terminus of the nascent polypeptide is removed (and presumably degraded) during anchor addition, there may be little advantage to synthesizing more than the minimum COOH-terminal sequence required to contain the GPI signal.
The absence of any detectable staining of the plasma membrane when permeabilized cells were stained with an antihGH antibody suggests that intact fusion molecules were not held on the cell surface in a non-GPI-anchored form. This observation that uncleaved fusion molecules are secreted rather than held in the plasma membrane as transmembrane proteins, suggests that the COOH-terminal hydrophobic domain of DAF (17 amino acids) does not function as a membrane anchor, being either insufficiently hydrophobic, or lacking additional stop-transfer signals. This implies that the hydrophobic domain functions as an actual recognition signal for GPI attachment rather than as a transient membrane anchor, as has been suggested. internally or at the COOH terminus, did not function as a translocation signal. Secondly, although negative results preclude a finn conclusion, it seems likely that membrane translocation is required for GPI anchor attachment.
